Investor
Invivo Partners
Invivo Partners is a venture capital firm based in Barcelona, Spain, specializing in early-stage investments in biotechnology and deep technology sectors, particularly in healthcare and AI-driven companies.
Online destinations
Find Invivo Partners online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
Invivo Partners is a venture capital firm that focuses on early-stage investments in biotechnology and deep technology, particularly at the intersection of artificial intelligence and healthcare. Founded by Dr. Luis Pareras and Albert Ferrer, the firm aims to foster growth in the health sector through impactful investments. With a portfolio of 17 companies and 4 successful exits, Invivo Partners is committed to supporting innovative ventures that address real-world problems. Their investment strategy includes initial investments ranging from €2-4 million, with follow-on investments up to €10 million, primarily targeting European-based companies.
Focus
Invivo Partners primarily invests in the biotechnology sector, targeting companies that develop innovative drugs, particularly in advanced therapies and synthetic biology. The firm also focuses on AI-driven companies that address real-world problems, with a significant emphasis on healthcare solutions. Initial investments range from €2-4 million, with follow-on investments up to €10 million per company after meeting specific milestones.
Support
Invivo Partners adds value to its portfolio companies through a combination of scientific, technical, and financial expertise, helping them navigate the complexities of drug development and market entry.
Questions
What are Invivo Partners' investment criteria?
Invivo Partners focuses on early-stage investments in biotechnology and AI-driven deep technology, particularly in healthcare. They seek companies with strong proof of concept and robust intellectual property.
How can startups apply or pitch to Invivo Partners?
Startups can pitch to Invivo Partners through their website at invivo.partners. It is recommended to include a detailed business plan and information on the team, market potential, and technology.
What makes Invivo Partners different from other venture capital firms?
Invivo Partners combines scientific, technical, and financial expertise to support its portfolio companies, helping them navigate the complexities of drug development and market entry.
What is the geographical scope of Invivo Partners' investments?
The firm primarily invests in European-based companies, with a particular emphasis on opportunities in Spain.
What is the typical fund size and check size for investments?
Invivo Partners manages a fund size of €100 million, with initial investments ranging from €2-4 million and follow-on investments up to €10 million per company.
What is Invivo Partners' post-investment involvement like?
Invivo Partners adds value through mentorship and support in navigating drug development, leveraging their extensive network and expertise in the biotech sector.
Check your startup’s fit
Check your startup’s fit with Invivo PartnersSimilar investors
Organizations that do similar work to Invivo Partners.
Investor
InvestorInvesting in private markets for over 30 years.
InvestorEight Roads is a global venture capital firm based in London, originally founded as Fidelity Ventures in 1969. The firm invests in technology and healthcare sectors across Asia, Europe, Israel, and the US, focusing on growth-stage companies.
InvestorEmpowering global enterprise AI startups from seed to IPO.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works